関連する実験動画
Updated: Feb 17, 2026

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.7K
体の外生命維持装置で管理されたトラウマにおけるフォン・ウィレブランド因子ダイナミクス
Teryn R Roberts1, Pamella A Villalobos2, Eric B Bigon2
1Autonomous Reanimation and Evacuation Research Institute, The Geneva Foundation, San Antonio, TX, USA; University of the Incarnate Word School of Osteopathic Medicine, San Antonio, TX, USA.
Journal of thrombosis and haemostasis : JTH
|February 15, 2026
まとめ
身体外生命維持装置 (ECLS) は,フォン・ウィレブランド因子 (VWF) に影響を及ぼすことによって出血を引き起こす可能性があります. ECLSのトラウマ患者は,VWFの枯渇は少ないが,VWFの機能は変化しており,獲得VWF症候群のリスクを示唆しています.
科学分野:
- 心血管医学 心血管医学
- 血液学 ヘマトロジ
- クリティカルケア・メディシン
背景:
- 身体外生命維持 (ECLS) は,ADAMTS13によるフォン・ウィレブランド因子 (VWF) の過度の割れによる出血と関連しており,取得したフォン・ウィレブランド症候群 (AVWS) につながっている.
- 高分子量VWFマルチメーター (VWF-HMWM) は凝固に不可欠であり,そのレベルは急性相応答とADAMTS13活動によって影響を受けます.
研究 の 目的:
- VWF-HMWMの分解とVWF:コラーゲン結合活性 (CB) /VWF:抗原 (Ag) の比率をECLS中の急性トラウマと非傷害の設定で比較する.
- ECLSとトラウマがVWFの構造機能関係とADAMTS13の活動に与える影響を評価する.
主な方法:
- 豚のモデルを使用し,ポリトラウマ (INJ-CTRL),損傷のないECLS (ECLS-CTRL),およびECLS (ECLS-INJ) を有するポリトラウマのグループにランダムに分けました.
- VWF:Ag,VWF:CB,VWFマルチマーサイズ分布,およびADAMTS13の活動は,ベースラインおよび72時間以上で測定されました.
- ECLSグループはヘパリン抗凝固薬または全身抗凝固薬を受けなかった.
主要な成果:
- VWF-HMWMの枯渇は,ECLS-CTRLでは72時間後に発生したが,ECLS-INJでは発生しなかった.
- VWF:CB/VWF:Agの比率は,ECLSの両方のグループで著しく減少したが,INJ-CTRLでは減少しなかった.
- ヘパリンはVWF-HMWMの分解を緩和し,VWF:CB/VWF:Ag比とADAMTS13の活性を維持した.
結論:
- ECLSのトラウマ患者は,VWF:CB/VWF:Ag比が低下し,ADAMTS13の活性が低下し,VWF-HMWMの減少は最小限に留まります.
- この発見は,ECLSを受けたトラウマ患者のAVWSの潜在的なリスクを強調しています.
- ヘパリンは,VWFとADAMTS13に対するECLSの悪影響を部分的に相殺し,潜在的な治療的役割を示唆しました.
関連する概念動画
Extrinsic and Intrinsic Pathways of Hemostasis
13.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
13.4K
Introduction to Hemostasis
14.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.8K
Coagulation
10.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
10.8K
Formation of the Platelet Plug
9.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.6K
Vascular Spasm
3.9K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
3.9K
Clot Retraction and Fibrinolysis
9.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.2K

